Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.50
Bid: 29.00
Ask: 30.00
Change: -0.50 (-1.67%)
Spread: 1.00 (3.448%)
Open: 29.50
High: 29.50
Low: 29.50
Prev. Close: 30.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update & Notice of Results

11 Nov 2020 07:00

RNS Number : 9031E
Ilika plc
11 November 2020
 

Ilika plc

("Ilika" or the "Company")

 

Trading Update

& Notice of Half-year Results

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology, is today providing an update on trading for the six months ended 31 October 2020.

 

Financial Highlights

 

Trading in the first half of the year has been broadly in-line with our expectations in accordance with our assessment of the financial impact of COVID-19 restrictions, which resulted in the three-month shutdown of the Stereax pilot line between March and June 2020. Despite the restrictions, revenue recognition for the period was £1.3m (H1 2019: £1.5m). The EBITDA loss for the period remained unchanged relative to the EBITDA loss for the same period last year at £1.0m (H1 2019: loss of £1.0m). Cash and cash equivalents at the period end were £12.4m (H1 2019: £1.9m).

 

Operating Highlights

 

StereaxÒ

Following the successful conclusion of our over-subscribed £15m equity placing in April 2020, the Company is now implementing the manufacturing scale-up plans for StereaxÒ, Ilika's miniature solid-state batteries designed for industrial wireless sensors in hostile environments and medical implants. This involves selecting a fabrication facility (FAB) into which the Company will install key equipment for its proprietary cell manufacturing process. The Company is well advanced with that selection process and still expects to finalise details by the end of 2020 with key tools, which have already been ordered, expected to be installed in the first half of FY22 and manufacturing commencing by the second half of FY22. This will result in a 70x increase in Stereax production capacity by the end of 2021. In order to manage this process the Company has made a key hire, Paul Marron, Technology Transfer Director.

 

Goliath Programme

The Company's continued collaborations with its Faraday Battery Challenge partners have resulted in a steady increase in the Goliath large format cell performance. The plans for the scale-up of the Goliath programme progressed in September 2020 with the announcement of the framework agreement with the UK Battery Industrialisation Centre, or UKBIC. Ilika's Goliath pre-pilot line in Romsey is a prototyping facility with a capacity of 1 kWh/week, which we intend to increase to 10 kWh/week by 2022 with the support of further grant funding. Beyond that, the UKBIC will facilitate the production of 5MWh/week, enabling the launch of the first Goliath-powered commercial products.

 

Notice of Results

 

Ilika expects to announce half-year results for the six months ended 31 October 2020 on Thursday 14 January 2021.

 

Analyst Briefing

The management team will be hosting a remote analyst briefing on the day, 14 January 2021, at 9.30am. Analysts who wish to attend should contact Lianne Cawthorne at Walbrook PR on +44(0)20 7933 8780 or email ilika@walbrookpr.com to register. 

 

Investor Presentation

An investor presentation will be held on the day, 14 January 2021, at 4.30pm and will be hosted through the digital platform, Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet Ilika plc via the following link: https://www.investormeetcompany.com/ilika-plc/register-investor

 or for more information please contact Walbrook PR at ilika@walbrookpr.com. 

 

Ilika's CEO Graeme Purdy, stated, "Despite the operational challenges posed by the restrictions accompanying the COVID-19 pandemic, Ilika has progressed both the implementation of its manufacturing plans for Stereax and continued the development of its Goliath large format cells. The Company has a clear pathway to increased production, revenue generation and cash flow break even, with a focus on a number of exciting target markets. We look forward to maintaining the on-schedule implementation of our plans in the second half of our current financial year and updating the market on our progress."

 

For more information contact:

 

Ilika plc

 

 

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR

Steve Boydell, Finance Director

 

 

 

Liberum Capital Limited

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan, William Hall, Nikhil Varghese

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Tom Cooper

Mob: 0797 122 1972

Lianne Cawthorne

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

 

Notes to editor and corporate video:

Please click link here to view latest corporate video and overview:

https://www.ilika.com/latest-news/ilika-investor-update-november-2020

Ilika plc (LON: IKA) is a pioneer in solid-state battery technology with their innovative Stereax micro batteries designed for Industrial IoT and MedTech markets, and their Goliath large format batteries for the electric vehicle and consumer electronics markets. Stereax battery technology offers compelling advantages over conventional lithium ion batteries, including smaller footprint, high energy density, non-toxic materials, faster charging, increased cycle life, low leakage and reduced flammability. Stereax solid-state batteries are also customisable in shape and form, stackable and operational at high temperatures.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFSFUSESSEIF
Date   Source Headline
17th Nov 20229:00 amRNSPrice Monitoring Extension
17th Nov 20227:01 amRNSAppointment of Chief Financial Officer
17th Nov 20227:00 amRNSTrading Update, Notice of Results & Presentations
22nd Sep 202212:45 pmRNSExercise of Options, PDMR Shareholding and TVR
20th Sep 20224:47 pmRNSResult of AGM
7th Sep 202210:00 amRNSGoliath Scale-up Update
18th Aug 20227:00 amRNSPosting of Annual Report and Notice of AGM
1st Aug 20229:05 amRNSSecond Price Monitoring Extn
1st Aug 20229:00 amRNSPrice Monitoring Extension
25th Jul 20223:30 pmRNSHolding(s) in Company
20th Jul 20222:05 pmRNSSecond Price Monitoring Extn
20th Jul 20222:00 pmRNSPrice Monitoring Extension
14th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jul 20224:41 pmRNSSecond Price Monitoring Extn
13th Jul 20224:36 pmRNSPrice Monitoring Extension
13th Jul 20227:00 amRNSFinal Results
20th Jun 20227:00 amRNSGoliath Scale-up Update
11th May 20227:00 amRNSTrading Update & Notice of Results
4th May 20227:00 amRNSGoliath Scale-up Update
21st Mar 202211:45 amRNSDirector/PDMR Shareholding
15th Mar 202212:34 pmRNSDirector/PDMR Shareholding
25th Feb 20227:00 amRNSDirectorate Change
24th Feb 20222:01 pmRNSPrice Monitoring Extension
8th Feb 20227:00 amRNSAward of Share Options
7th Feb 202211:01 amRNSPrice Monitoring Extension
20th Jan 20227:00 amRNSHalf-year Report
6th Dec 20217:00 amRNSFirst Stereax Manufacturing Facility Opened
23rd Nov 20215:11 pmRNSHolding(s) in Company
19th Nov 20217:00 amRNSTrading Update & Notice of Half-year Results
10th Nov 20217:00 amRNSCapital Markets Day
22nd Sep 20213:30 pmRNSResult of AGM and Award of Bonus Share Options
10th Sep 20217:00 amRNSCommencement of trading on OTCQX Best Market in US
7th Sep 20217:00 amRNSSenior Appointments and Change of Director
24th Aug 20217:00 amRNSStereax Manufacturing Update
20th Aug 20217:00 amRNSNotice of AGM & Posting of Annual Report
5th Aug 20219:16 amRNSExercise of Options and Total Voting Rights
30th Jul 20214:32 pmRNSHolding(s) in Company
30th Jul 20219:54 amRNSDirector/PDMR Shareholding
29th Jul 20219:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20211:14 pmRNSResults of GM, Open Offer and Total Voting Rights
12th Jul 202112:30 pmRNSPosting of Circular
9th Jul 20214:07 pmRNSResult of Placing and Retail Offer
9th Jul 20217:01 amRNSRetail Offer
9th Jul 20217:00 amRNSProposed Placing, Open Offer and Retail Offer
6th Jul 20217:00 amRNSFinal Results
5th Jul 202111:05 amRNSSecond Price Monitoring Extn
5th Jul 202111:00 amRNSPrice Monitoring Extension
23rd Jun 202111:06 amRNSSecond Price Monitoring Extn
23rd Jun 202111:05 amRNSPrice Monitoring Extension
22nd Jun 20219:02 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.